Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
doi: 10.1016/0277-9536(95)80007-7 185
Its unusual stability in acidic environments sets it apart from conventional peptides: the literature has reported a meaningful half-life at pH 2 and resistance to digestive proteases, making it a unique subject of study within the regenerative research peptide class
Thymosin Beta-4 was studied extensively in racehorses before transitioning to human research contexts, and that veterinary track record helped establish its safety profile before clinical use
The route depends on the primary indication: oral BPC-157 targets the GI tract more directly, while injectable BPC-157 provides systemic distribution for musculoskeletal applications
BPC-157 + TB-500 remains an investigational research product and is intended exclusively for scientific and laboratory research applications
US$ 23.58
US$ 28.41
US$ 20.31
US$ 24.61
US$ 23.75
US$ 25.86
US$ 25.83
US$ 27.49
US$ 20.79
US$ 23.27
US$ 25.30
